Columbia University/Herbert Irving Cancer Center — New York, New York

Columbia University/Herbert Irving Cancer Center is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Columbia University/Herbert Irving Cancer Center has participated in 46 clinical trials with 3 currently active.

Therapeutic areas: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), Children's Oncology Group.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University/Herbert Irving Cancer Center?

Columbia University/Herbert Irving Cancer Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University/Herbert Irving Cancer Center conducted?

Columbia University/Herbert Irving Cancer Center has 46 clinical trials on record, with 3 currently active. Their work covers Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Is Columbia University/Herbert Irving Cancer Center accredited by Crixeo Health?

Yes — Columbia University/Herbert Irving Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Columbia University/Herbert Irving Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.